A., & Sullivan, D
Currently, a phase Ib/II clinical trial is underway to explore the combination of anakinra with CAR-T therapy for the management of relapsed multiple myeloma [320]
S-Acetyl-Glutathione Attenuates Carbon Tetrachloride-Induced Liver Injury by Modulating Oxidative Imbalance and Inflammation
Whether or not every detail of that model is correct, it explains why researchers treated GHK-Cu as a candidate systemic repair signal rather than merely a local additive, and why they were willing to inject it into wound compartments and whole animals to see what a supraphysiologic systemic dose would do
Published human evidence includes topical applications over defined periods, diabetic-ulcer wound protocols, and a registered topical acute-wound trial, while there is no FDA-approved injectable GHK-Cu label that establishes a standard dose [2], [3], [7], [8]
This pilot study evaluated BPC-157 in patients with interstitial cystitis, making it one of the few human trials